The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation.

ESRRA PPARA chronic kidney disease fatty-acid oxidation fibrosis kidney organoids proximal tubule cells single-cell ATAC sequencing single-cell RNA sequencing

Journal

Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170

Informations de publication

Date de publication:
02 02 2021
Historique:
received: 25 02 2020
revised: 28 08 2020
accepted: 12 11 2020
pubmed: 11 12 2020
medline: 30 11 2021
entrez: 10 12 2020
Statut: ppublish

Résumé

Kidney disease is poorly understood because of the organ's cellular diversity. We used single-cell RNA sequencing not only in resolving differences in injured kidney tissue cellular composition but also in cell-type-specific gene expression in mouse models of kidney disease. This analysis highlighted major changes in cellular diversity in kidney disease, which markedly impacted whole-kidney transcriptomics outputs. Cell-type-specific differential expression analysis identified proximal tubule (PT) cells as the key vulnerable cell type. Through unbiased cell trajectory analyses, we show that PT cell differentiation is altered in kidney disease. Metabolism (fatty acid oxidation and oxidative phosphorylation) in PT cells showed the strongest and most reproducible association with PT cell differentiation and disease. Coupling of cell differentiation and the metabolism was established by nuclear receptors (estrogen-related receptor alpha [ESRRA] and peroxisomal proliferation-activated receptor alpha [PPARA]) that directly control metabolic and PT-cell-specific gene expression in mice and patient samples while protecting from kidney disease in the mouse model.

Identifiants

pubmed: 33301705
pii: S1550-4131(20)30606-9
doi: 10.1016/j.cmet.2020.11.011
pmc: PMC9259369
mid: NIHMS1817578
pii:
doi:

Substances chimiques

Receptors, Estrogen 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-394.e8

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK111495
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK087635
Pays : United States
Organisme : NIDDK NIH HHS
ID : DP3 DK108220
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK076077
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK105821
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The Susztak lab is supported by Boehringer Ingelheim, Lilly, Regeneron, GSK, Merck, Bayer, and Gilead for work that is not related to the current manuscript.

Références

Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4910-E4919
pubmed: 29735694
J Am Soc Nephrol. 2009 Apr;20(4):765-76
pubmed: 19297557
Stem Cells. 2012 Aug;30(8):1714-25
pubmed: 22628275
Cell Rep. 2019 Aug 6;28(6):1485-1498.e6
pubmed: 31390563
Am J Kidney Dis. 2016 Jul;68(1):19-28
pubmed: 26948834
Cell Rep. 2019 Oct 29;29(5):1261-1273.e6
pubmed: 31665638
Lancet. 2017 Oct 21;390(10105):1888-1917
pubmed: 28434650
J Am Soc Nephrol. 2010 Aug;21(8):1247-53
pubmed: 20651165
Nat Commun. 2019 Jun 27;10(1):2832
pubmed: 31249312
Diabetes. 2011 Sep;60(9):2354-69
pubmed: 21752957
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
J Exp Med. 2013 Sep 23;210(10):2119-34
pubmed: 24043759
Sci Signal. 2018 Jun 26;11(536):
pubmed: 29945885
J Clin Invest. 2011 Oct;121(10):4003-14
pubmed: 21881206
Lancet Diabetes Endocrinol. 2014 May;2(5):369-84
pubmed: 24795251
Nature. 2016 Mar 24;531(7595):528-32
pubmed: 26982719
Nature. 2011 Jul 04;476(7360):293-7
pubmed: 21727895
Nat Rev Drug Discov. 2016 Aug;15(8):568-88
pubmed: 27230798
Nat Med. 2015 Jan;21(1):37-46
pubmed: 25419705
Nat Genet. 2019 Jun;51(6):957-972
pubmed: 31152163
Nat Med. 2018 Nov;24(11):1721-1731
pubmed: 30275566
Cell Stem Cell. 2018 Dec 6;23(6):869-881.e8
pubmed: 30449713
Sci Transl Med. 2015 Feb 11;7(274):274ra18
pubmed: 25673763
Cell Rep. 2016 Feb 2;14(4):861-871
pubmed: 26776520
Nat Rev Nephrol. 2017 Jan;13(1):39-46
pubmed: 27890924
Nat Rev Nephrol. 2016 Jul;12(7):426-39
pubmed: 27140856
Nat Commun. 2019 Aug 26;10(1):3842
pubmed: 31451708
PLoS Biol. 2018 Sep 18;16(9):e2005233
pubmed: 30226866
Curr Protoc Mouse Biol. 2017 Mar 2;7(1):47-54
pubmed: 28252199
Cell Metab. 2017 Jun 6;25(6):1282-1293.e7
pubmed: 28416194
EBioMedicine. 2017 Oct;24:267-276
pubmed: 28970079
Bioinformatics. 2015 May 15;31(10):1584-91
pubmed: 25583121
PLoS One. 2014 Mar 27;9(3):e93460
pubmed: 24675717
Nat Med. 2015 Sep;21(9):989-97
pubmed: 26236989
Nat Mater. 2019 Apr;18(4):397-405
pubmed: 30778227
Genome Med. 2019 Jan 23;11(1):3
pubmed: 30674341
J Clin Invest. 2014 Mar;124(3):1242-54
pubmed: 24569379
JCI Insight. 2020 Mar 26;5(6):
pubmed: 32107344
Science. 2018 May 18;360(6390):758-763
pubmed: 29622724
Immunity. 2009 Jun 19;30(6):832-44
pubmed: 19538929
J Clin Invest. 2014 Jun;124(6):2333-40
pubmed: 24892707
Nat Med. 2015 Sep;21(9):998-1009
pubmed: 26236991
Kidney Int. 2012 May;81(9):880-91
pubmed: 22278018
Nat Immunol. 2017 Sep;18(9):1025-1034
pubmed: 28737753
Cell Rep. 2014 May 22;7(4):1270-83
pubmed: 24835991
Diabetes. 2006 Jun;55(6):1783-91
pubmed: 16731843
Science. 2018 Sep 28;361(6409):1380-1385
pubmed: 30166440
Cell Syst. 2019 Apr 24;8(4):329-337.e4
pubmed: 30954475
J Immunol. 2011 Mar 15;186(6):3299-303
pubmed: 21317389
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
J Clin Invest. 2015 Jan;125(1):141-56
pubmed: 25415439
Cell. 2019 Jul 25;178(3):714-730.e22
pubmed: 31348891
J Am Soc Nephrol. 2020 Nov;31(11):2543-2558
pubmed: 32764140
Cell Metab. 2019 Oct 1;30(4):784-799.e5
pubmed: 31474566
J Am Soc Nephrol. 2019 Jan;30(1):23-32
pubmed: 30510133
J Biol Chem. 2011 Jul 22;286(29):26003-15
pubmed: 21613219
J Cell Mol Med. 2019 Jun;23(6):3995-4004
pubmed: 30993884
Ann Intern Med. 2013 Aug 20;159(4):233-42
pubmed: 24026256
J Clin Invest. 2010 Nov;120(11):4040-54
pubmed: 20978353
Science. 2018 Apr 27;360(6387):449-453
pubmed: 29599194
Science. 2018 Aug 10;361(6402):594-599
pubmed: 30093597

Auteurs

Poonam Dhillon (P)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Jihwan Park (J)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; School of Life Sciences, Gwangju Institute of Science and Technology (GIST), 123 Cheomdangwagi-ro, Buk-gu, Gwangju, Republic of Korea. Electronic address: jihwan.park@gist.ac.kr.

Carmen Hurtado Del Pozo (C)

Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Technology (BIST), Barcelona, Spain.

Lingzhi Li (L)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Tomohito Doke (T)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Shizheng Huang (S)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Juanjuan Zhao (J)

Center for Mitochondrial and Epigenomic Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Hyun Mi Kang (HM)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Laboratory of Disease Modeling and Therapeutics, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.

Rojesh Shrestra (R)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Michael S Balzer (MS)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Shatakshee Chatterjee (S)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Patricia Prado (P)

Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Technology (BIST), Barcelona, Spain.

Seung Yub Han (SY)

Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Hongbo Liu (H)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Xin Sheng (X)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Pieterjan Dierickx (P)

Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Kirill Batmanov (K)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Juan P Romero (JP)

Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Oncohematology Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Hematology and Area of Cell Therapy, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.

Felipe Prósper (F)

Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Oncohematology Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Hematology and Area of Cell Therapy, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.

Mingyao Li (M)

Department of Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

Liming Pei (L)

Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Mitochondrial and Epigenomic Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Junhyong Kim (J)

Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Nuria Montserrat (N)

Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Technology (BIST), Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Madrid, Spain. Electronic address: nmontserrat@ibecbarcelona.eu.

Katalin Susztak (K)

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: ksusztak@pennmedicine.upenn.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH